IRVINE, CA--(Marketwired - Sep 5, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC) are pleased to announce significantly positive analytical lab testing reports from its San Joaquin Sovereign Tribal Free Land MBS, Industrial Hemp Project. Initial analytical reports from the first cut plants reveals that the strains being used are well within the boundaries of laws and regulations placed on industrial hemp research projects of this sort.
The lab results from the 2017 CBIS/FSO NAC MBS001 initial harvest show values of THC 0.26% and CBD at 5%. This is a critical initial sign with a ratio of CBD to THC for the strains tested since these strains were chosen specifically for this reason. Industrial Hemp has certain regulatory levels of cannabinoids allowed for legal regulatory status across the country. As compared to cannabis the cannabinoid levels are much lower in hemp, which gives it a much lower overdose concern from misuse, abuse, and public consumption.
A Robust University Infrastructure Focused on Education and Job Creation
With the Universities at the helm, their main function is the complete oversight and mind mapping of the Native American educational and economic development initiative by extensively using its research and development programs:
1. A primary goal of Raymond C. Dabney University (RCDU), a school of Law, Business, and Healthcare, is to provide financially-challenged communities a creative and affordable opportunity to acquire a quality education beginning with structured and regulated programs in each of its three main curriculums along with its entrepreneurial job creation program.
2. American States University (ASU) is an intricate part of each land package deal with CBIS/FSO NAC, along with RCDU it expects to provide full scholarships and additionally subsidized education packages from its 37 Trade Industries including alternative medicines to members of the Native American community and any other challenged individuals to grow with the initiative.
Our agricultural research programs drive our pharmaceutical and alternative medicines programs. Our alternative medicines program is designed to drive our success. Our University Alternative Medicine program, which grows out of our Agriculture training program integrates several of our programs and becomes a comprehensive educational and economic development approach wherever we create our project. We have the following infrastructure:
1. ASU has an alternative medicine program that it has been approved for by the state of California.
a. We will use this program to create curricula for each of the areas of economic development for the creation of alternative medicines.
b. We point out each target indication cannabinoid drug development program will also include covers the development of alternative medicines.
2. We will create curricula for each area that will include:
a. Regulatory compliance
b. Company creation and structure
c. Department Management teams and operating staff
d. Planting to Harvest
e. Laboratory testing to formulation creation
f. Manufacturing and distribution
g. Observational and clinical studies
h. Sales and Marketing
The universities are also approved for the development of curricula in the following areas and we will create programs for student to learn real-world skills and entrepreneurial competencies:
1. The development of alternative biofuels,
2. The development of construction materials from plants,
3. The development of clothing materials,
4. The development of automobile parts, and
5. The development of rope and strings.
For the remainder of 2017, the San Joaquin Sovereign Tribal Free Land MBS in California, Cannabis Science and FSO NAC will continue working closely in sync with the Universities chosen for this substantial research project. The main goals are to vertically integrate operations to provide a large amount of many jobs throughout the community in agriculture, education, healthcare training, construction, and general retail services for the completion of the 2017, CBIS/FSO NAC MBS001 harvest;
(1) To include Academic and vocational training covering each applied industry;
(2) Agricultural focused research;
(3) Development of healthcare infrastructure, including hospitals and health centers;
(4) Pharmaceutical and Alternative Medicines development;
(5) Creation of a sustainable, food security system that is based on sound agricultural practices that produce sufficient food for consumption and that are designed to reduce poverty and allow for real farm-to-table programs;
(6) Development of water management systems; and
(7) Development of waste management systems that reduce the prevalence of critical risk factors for infectious diseases.
(8) Investment in communications infrastructure, to include satellite, Internet, mechanical device development, and cellphone infrastructure; and
(9) Support for policy, regulatory, and jurisdictional environments, as they pertain to public healthcare, agriculture, education, job creation, and most important; on the job training oriented for success.
To date, there have been approximately 25-30 part-time workers hired so far, and it is expected that another 50-75 people will be hired before the harvest is completed. The harvesting process is very labor intensive and very seasonal until the staggering process has been completed for year around harvesting. At that point, the Company expects there will be constantly new jobs being created as the employment requirement will substantially increase to the number of full-time permanent staff to increase substantially living in the area to service the full 250 acres for this project and any required expansions.
A Robust University Education and Job Creation Infrastructure:
For the remainder of 2017, the San Joaquin Sovereign Tribal Free Land MBS in California, Cannabis Science and FSO NAC will implement an economic development plan that is expected to include the Company and the Universities in vertically-integrated operations to provide jobs throughout the community for in education, medical healthcare training, construction, and general services for the completion of the University industrial hemp commercial research program scheduled for the 2017, CBIS/FSO NAC MBS001. The initial laboratory research is quite extensive as plants are harvested and ready for preliminary dry and wet extraction, with and two-phase testing. These targets include agricultural research for alternative medicines, pharmaceutical development program for medicines targeting critical ailments, wholesale distribution to physicians and licensed wholesale manufacturers coupled with extraction research and development for green energy/fuel, construction materials, clothing fabric, paper manufacturing, food products, vehicle production parts, and biomass soil, the industries are many.
About Cannabis Science, Inc.
Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Dr. Allen Herman
Chief Medical Officer (CMO)
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder